TITLE

Antibacterials/insulin detemir/omeprazole interaction

PUB. DATE
August 2013
SOURCE
Reactions Weekly;8/1/2013, Issue 1463, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a case study of an 82-year-old man with hypoglycaemia, which developed during treatment with amoxicillin, clarithromycin, omeprazole and insulin detemir for type 2 diabetes.
ACCESSION #
89517987

 

Related Articles

  • An Open, Randomized, Parallel-Group Study to Compare the Efficacy and Safety Profile of Inhaled Human Insulin (Exubera) With Metformin as Adjunctive Therapy in Patients With Type 2 Diabetes Poorly Controlled on a Sulfonylurea. Barnett, Anthony H.; Dreyer, Manfred; Lange, Peter; Serdarevic-Pehar, Marjana // Diabetes Care;Jun2006, Vol. 29 Issue 6, p1282 

    OBJECTIVE -- To compare the efficacy and safety profile of adding inhaled human insulin (INH; Exubera) or metformin to sulfonylurea monotherapy in patients with poorly controlled type 2 diabetes. RESEARCH DESIGN AND METHODS -- We performed an open-label, parallel, 24-week, multicenter trial. At...

  • Nateglinide in Combination with Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A Post-Marketing Surveillance Study. Yang, Jin-Kui; Wang, Lei // Clinical Drug Investigation;2013, Vol. 33 Issue 3, p185 

    Background and Objective: Diabetes mellitus has become a major public health problem in China. This open-label, prospective, multicentre, post-marketing surveillance study was conducted to investigate the efficacy and safety of nateglinide in combination with metformin in Chinese patients with...

  • Glucose-Lowering Effects of Sulfasalazine in Type 2 Diabetes. Haas, Romana M.; Li, Phoebe; Chu, James W. // Diabetes Care;Sep2005, Vol. 28 Issue 9, p2238 

    Presents the case of a 37-year-old woman with systemic lupus erythematosus and type 2 diabetes on high-dose insulin therapy who experienced recurrent severe hypoglycemia after the initiation of sulfasalazine and eventually achieved normoglycemia without the need for diabetes medications. ...

  • HYPOGLYCEMIC AGENTS, ORAL.  // Davis's Drug Guide for Nurses, 10th edition;2007, p616 

    The article presents a nursing guide for several oral hypoglycemic agents, including glimepiride, glipizide, and glyburide, drugs used for controlling blood glucose in patients with non-insulin-dependent diabetes mellitus. The mechanism of action of the drug is discussed. Information on its...

  • Gliclazide interaction.  // Reactions Weekly;8/20/2005, Issue 1065, p11 

    Presents the case of an elderly patient who developed hypoglycaemia coma after receiving gliclazide interaction with cotrimoxazole for type 2 diabetes and urinary tract infection. Dosage of cotrimoxazole administered to the patient.

  • Repaglinide.  // Reactions Weekly;9/5/2009, Issue 1268, p26 

    The article describes the case of an 82-year-old man who experienced hypoglycaemia while receiving repaglinide for type 2 diabetes mellitus. He was presented with confusion and dizziness which appeared 20 minutes prior to arrival. Particular focus is given to the results of laboratory...

  • Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight without Risk of Hypoglycemia in Patients With Type 2 Diabetes. Vilsbøll, Tina; Zdravkovic, Milan; Le-Thi, Tu; Krarup, Thure; Schmitz, Ole; Courrèges, Jean-Pierre; Verhoeven, Robert; Bugánová, Ingrid; Madsbad, Sten // Diabetes Care;Jun2007, Vol. 30 Issue 6, p1608 

    The article presents information on a study conducted to evaluate the efficacy and safety of treatment with liraglutide, a human glucagon-like peptide-1 (GLP-1) analog, in patients with type 2 diabetes. Results showed that the placebo group accounted for almost one-half of the patient...

  • WHEN TO SAY NO TO THIS DRUG. Harrar, Sari; L.T. // Prevention;Aug2002, Vol. 54 Issue 8, p146 

    Reports on the serious and potentially life-threatening side effect, lactic acidosis, that can result from taking metformin, a drug used to treat type 2 diabetes.

  • Liraglutide.  // Reactions Weekly;May2015, Vol. 1553 Issue 1, p201 

    The article presents a case study of a 46-year-old woman who experienced acute pancreatitis while treated with liraglutide for her type 2 diabetes mellitus.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics